Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1979 1
1983 1
1984 5
1985 4
1989 3
1990 6
1991 6
1992 11
1993 9
1994 5
1995 3
1996 8
1997 4
1998 9
1999 5
2000 3
2001 4
2002 5
2003 7
2004 5
2006 1
2007 4
2008 1
2009 4
2010 2
2011 4
2012 3
2013 5
2014 4
2015 3
2016 2
2017 1
2018 2
2019 4
2020 2
2021 3
2024 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

148 results

Results by year

Filters applied: . Clear all
Page 1
Mitochondrial dysfunction and immune suppression in BRAF V600E-mutated metastatic melanoma.
Pinto de Almeida N, Jánosi ÁJ, Hong R, Rajeh A, Nogueira F, Szadai L, Szeitz B, Pla Parada I, Doma V, Woldmar N, Guedes J, Újfaludi Z, Bartha A, Kim Y, Welinder C, Baldetorp B, Kemény LV, Pahi Z, Wan G, Nguyen N, Pankotai T, Győrffy B, Pawłowski K, Horvatovich P, Szasz AM, Sanchez A, Kuras M, Rodriguez Murillo J, Betancourt L, Domont GB, Semenov YR, Yu KH, Kwon HJ, Németh IB, Fenyő D, Wieslander E, Marko-Varga G, Gil J. Pinto de Almeida N, et al. Among authors: baldetorp b. Clin Transl Med. 2024 Jul;14(7):e1773. doi: 10.1002/ctm2.1773. Clin Transl Med. 2024. PMID: 39032005 Free PMC article. No abstract available.
The human melanoma proteome atlas-Defining the molecular pathology.
Betancourt LH, Gil J, Kim Y, Doma V, Çakır U, Sanchez A, Murillo JR, Kuras M, Parada IP, Sugihara Y, Appelqvist R, Wieslander E, Welinder C, Velasquez E, de Almeida NP, Woldmar N, Marko-Varga M, Pawłowski K, Eriksson J, Szeitz B, Baldetorp B, Ingvar C, Olsson H, Lundgren L, Lindberg H, Oskolas H, Lee B, Berge E, Sjögren M, Eriksson C, Kim D, Kwon HJ, Knudsen B, Rezeli M, Hong R, Horvatovich P, Miliotis T, Nishimura T, Kato H, Steinfelder E, Oppermann M, Miller K, Florindi F, Zhou Q, Domont GB, Pizzatti L, Nogueira FCS, Horvath P, Szadai L, Tímár J, Kárpáti S, Szász AM, Malm J, Fenyö D, Ekedahl H, Németh IB, Marko-Varga G. Betancourt LH, et al. Among authors: baldetorp b. Clin Transl Med. 2021 Jul;11(7):e473. doi: 10.1002/ctm2.473. Clin Transl Med. 2021. PMID: 34323403 Free PMC article.
Drug compound characterization by mass spectrometry imaging in cancer tissue.
Kwon HJ, Kim Y, Sugihara Y, Baldetorp B, Welinder C, Watanabe K, Nishimura T, Malm J, Török S, Döme B, Végvári Á, Gustavsson L, Fehniger TE, Marko-Varga G. Kwon HJ, et al. Among authors: baldetorp b. Arch Pharm Res. 2015 Sep;38(9):1718-27. doi: 10.1007/s12272-015-0627-2. Epub 2015 Jul 23. Arch Pharm Res. 2015. PMID: 26198812 Review.
The Human Melanoma Proteome Atlas-Complementing the melanoma transcriptome.
Betancourt LH, Gil J, Sanchez A, Doma V, Kuras M, Murillo JR, Velasquez E, Çakır U, Kim Y, Sugihara Y, Parada IP, Szeitz B, Appelqvist R, Wieslander E, Welinder C, de Almeida NP, Woldmar N, Marko-Varga M, Eriksson J, Pawłowski K, Baldetorp B, Ingvar C, Olsson H, Lundgren L, Lindberg H, Oskolas H, Lee B, Berge E, Sjögren M, Eriksson C, Kim D, Kwon HJ, Knudsen B, Rezeli M, Malm J, Hong R, Horvath P, Szász AM, Tímár J, Kárpáti S, Horvatovich P, Miliotis T, Nishimura T, Kato H, Steinfelder E, Oppermann M, Miller K, Florindi F, Zhou Q, Domont GB, Pizzatti L, Nogueira FCS, Szadai L, Németh IB, Ekedahl H, Fenyö D, Marko-Varga G. Betancourt LH, et al. Among authors: baldetorp b. Clin Transl Med. 2021 Jul;11(7):e451. doi: 10.1002/ctm2.451. Clin Transl Med. 2021. PMID: 34323402 Free PMC article.
Heterogenous mismatch-repair status in colorectal cancer.
Joost P, Veurink N, Holck S, Klarskov L, Bojesen A, Harbo M, Baldetorp B, Rambech E, Nilbert M. Joost P, et al. Among authors: baldetorp b. Diagn Pathol. 2014 Jun 26;9:126. doi: 10.1186/1746-1596-9-126. Diagn Pathol. 2014. PMID: 24968821 Free PMC article.
A new look at drugs targeting malignant melanoma--an application for mass spectrometry imaging.
Sugihara Y, Végvári A, Welinder C, Jönsson G, Ingvar C, Lundgren L, Olsson H, Breslin T, Wieslander E, Laurell T, Rezeli M, Jansson B, Nishimura T, Fehniger TE, Baldetorp B, Marko-Varga G. Sugihara Y, et al. Among authors: baldetorp b. Proteomics. 2014 Sep;14(17-18):1963-70. doi: 10.1002/pmic.201300476. Epub 2014 Aug 18. Proteomics. 2014. PMID: 25044963 Review.
Predicting immune checkpoint therapy response in three independent metastatic melanoma cohorts.
Szadai L, Bartha A, Parada IP, Lakatos AIT, Pál DMP, Lengyel AS, de Almeida NP, Jánosi ÁJ, Nogueira F, Szeitz B, Doma V, Woldmar N, Guedes J, Ujfaludi Z, Pahi ZG, Pankotai T, Kim Y, Győrffy B, Baldetorp B, Welinder C, Szasz AM, Betancourt L, Gil J, Appelqvist R, Kwon HJ, Kárpáti S, Kuras M, Murillo JR, Németh IB, Malm J, Fenyö D, Pawłowski K, Horvatovich P, Wieslander E, Kemény LV, Domont G, Marko-Varga G, Sanchez A. Szadai L, et al. Among authors: baldetorp b. Front Oncol. 2024 Jul 2;14:1428182. doi: 10.3389/fonc.2024.1428182. eCollection 2024. Front Oncol. 2024. PMID: 39015503 Free PMC article.
Predicting immune checkpoint therapy response in three independent metastatic melanoma cohorts.
Szadai L, Bartha A, Parada IP, Lakatos A, Pál D, Lengyel AS, de Almeida NP, Jánosi ÁJ, Nogueira F, Szeitz B, Doma V, Woldmar N, Guedes J, Ujfaludi Z, Pahi ZG, Pankotai T, Kim Y, Győrffy B, Baldetorp B, Welinder C, Szasz AM, Betancourt L, Gil J, Appelqvist R, Kwon HJ, Kárpáti S, Kuras M, Murillo JR, Németh IB, Malm J, Fenyö D, Pawłowski K, Horvatovich P, Wieslander E, Kemény LV, Domont G, MarkoVarga G, Sanchez A. Szadai L, et al. Among authors: baldetorp b. bioRxiv [Preprint]. 2024 May 4:2024.05.01.592032. doi: 10.1101/2024.05.01.592032. bioRxiv. 2024. Update in: Front Oncol. 2024 Jul 02;14:1428182. doi: 10.3389/fonc.2024.1428182. PMID: 38746333 Free PMC article. Updated. Preprint.
Clinical protein science in translational medicine targeting malignant melanoma.
Gil J, Betancourt LH, Pla I, Sanchez A, Appelqvist R, Miliotis T, Kuras M, Oskolas H, Kim Y, Horvath Z, Eriksson J, Berge E, Burestedt E, Jönsson G, Baldetorp B, Ingvar C, Olsson H, Lundgren L, Horvatovich P, Murillo JR, Sugihara Y, Welinder C, Wieslander E, Lee B, Lindberg H, Pawłowski K, Kwon HJ, Doma V, Timar J, Karpati S, Szasz AM, Németh IB, Nishimura T, Corthals G, Rezeli M, Knudsen B, Malm J, Marko-Varga G. Gil J, et al. Among authors: baldetorp b. Cell Biol Toxicol. 2019 Aug;35(4):293-332. doi: 10.1007/s10565-019-09468-6. Epub 2019 Mar 21. Cell Biol Toxicol. 2019. PMID: 30900145 Free PMC article.
Deep Proteomic Analysis on Biobanked Paraffine-Archived Melanoma with Prognostic/Predictive Biomarker Read-Out.
Szadai L, Velasquez E, Szeitz B, Almeida NP, Domont G, Betancourt LH, Gil J, Marko-Varga M, Oskolas H, Jánosi ÁJ, Boyano-Adánez MDC, Kemény L, Baldetorp B, Malm J, Horvatovich P, Szász AM, Németh IB, Marko-Varga G. Szadai L, et al. Among authors: baldetorp b. Cancers (Basel). 2021 Dec 3;13(23):6105. doi: 10.3390/cancers13236105. Cancers (Basel). 2021. PMID: 34885218 Free PMC article.
148 results